CNS Pharmaceuticals, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
CNS Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • CNS Pharmaceuticals, Inc. Return On Assets for the quarter ending September 30, 2024 was -515 %, a 102% decline year-over-year.
  • CNS Pharmaceuticals, Inc. annual Return On Assets for 2023 was -421 %, a 252% decline from 2022.
  • CNS Pharmaceuticals, Inc. annual Return On Assets for 2022 was -120 %, a 1.57% increase from 2021.
  • CNS Pharmaceuticals, Inc. annual Return On Assets for 2021 was -122 %, a 6.61% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.